Company: IPSC
Filing Date: 2025-07-10
Form Type: S-3
Source: 0001104659-25-067022
Chunk: 44

Company: Century Therapeutics, Inc.
Filing Date: 2025-07-10
Form: S-3
Chunk 44
---
 generally requires that, when acting on behalf of the corporation, directors and officers exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director or officer will not be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for liability for: • any breach of the director or officer’s duty of loyalty to the Company or its stockholders; • any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; • any act related to unlawful stock repurchases, redemptions, or other distributions or payment of dividends; or • any transaction from which the director or officer derived an improper personal benefit. These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. The Company’s Certificate of Incorporation authorizes the Company to indemnify its officers, directors and other agents to the fullest extent permitted under Delaware law. As permitted by Section 145 of the DGCL, the Company’s amended and restated bylaws provide that: • the Company may indemnify its directors, officers, and employees to the fullest extent permitted by the DGCL, subject to limited exceptions;

II-1

TABLE OF CONTENTS

• the Company may advance expenses to its directors, officers, and employees in connection with a legal proceeding to the fullest extent permitted by the DGCL, subject to limited exceptions; and • the rights provided in the Company’s amended and restated bylaws are not exclusive. The Company’s Certificate of Incorporation and its amended and restated bylaws provide for the indemnification provisions described above and elsewhere herein. The Company has entered into indemnification agreements with the Company’s directors and officers that may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements generally require the Company, among other things, to indemnify its officers and directors against certain liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also generally require the Company to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of the Company’s officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act. The Company maintains insurance on behalf of each and every person who is or was a director or